Efficacy News and Research

RSS

Researchers target cancer's protective barrier

Cancer cells are notorious for their camouflage work, which enables them to escape immune targeting. Now scientists are learning how to strip away the disguise and allow the immune system to do its work, by targeting cells called myeloid-derived suppressor cells (MDSCs) that shield the tumor. This would also enhance the effectiveness of newer cancer immunotherapies like Chimeric-Antigen Receptor T cell (CAR-T).

26 Aug 2019

Addiction clinics market pricey, unproven treatments to desperate patients

Jason was hallucinating. He was withdrawing from drugs at an addiction treatment center near Indianapolis, and he had hardly slept for several days.

23 Aug 2019

New insights into improving function, independence and quality of life in cerebral palsy patients

Cerebral palsy is one of the most common movement disorders in children. A growing number of caregivers worldwide are caring for children, adolescents and adults with child-onset CP.

23 Aug 2019

Head-to-head comparison of three breast cancer drugs reveals important differences

Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form--which tests positive for hormone receptors (HR+) and negative for the HER2 receptor--usually respond well to treatment.

23 Aug 2019

Slow electrons to fight cancer

Ion beams are often used today in cancer treatment: this involves electrically charged atoms being fired at the tumor to destroy cancer cells.

22 Aug 2019

New cannabis-based drug shows promise for pancreatic cancer

Cancer of the pancreas is a particularly deadly cancer, claiming over 90% of its victims within 5 years from diagnosis. It resists most standard therapies, including surgery, chemotherapy, radiation therapy, immunotherapy and targeted therapy, and metastasizes early, often before being diagnosed. A cure is possible only with very localized tumors.

22 Aug 2019

Massage Therapy Foundation announces research grant to address pain and opioid use in veterans

The Massage Therapy Foundation has awarded $210,000 for a research grant to the Defense and Veterans Center for Integrative Pain Management, Rockville, Md. Dr. Krista Highland, Deputy Director of Science, DVCIPM, is the Primary Investigator of the two-year study, "Massage Service Integration in a Military Primary Care Clinic: Implementation and Impact Study."

21 Aug 2019

'The Hemp and CBD Expo' returns to Birmingham on September 14-15th, 2019

The UK’s first Hemp & CBD Trade Show returns to Birmingham, welcoming 8000+ visitors.

21 Aug 2019

Northern Antibiotics working on a new molecule to fight antibiotic-resistant bacteria

Each year, around 60,000 deaths are caused by antibiotic-resistant bacteria in Europe and the U.S., and this number is growing.

21 Aug 2019

Measles back in UK three years after elimination

The United Kingdom was declared to be free of measles infection three years back in 2016 by the World Health Organization (WHO). In a recent development, due to the increasing number of cases of measles among unvaccinated children, the WHO has declared that UK can no longer be called measles-free.

20 Aug 2019

Ohio University scientists win $1.7 million grant for research on non-melanoma skin cancers

The National Institute of Environmental Health Sciences has awarded Ohio University scientists Shiyong Wu and Lingying Tong a five-year $1.7 million grant to advance research on a potential prevention and treatment for non-melanoma skin cancers.

20 Aug 2019

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients

Merkel cell carcinoma is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each year in the United States.

20 Aug 2019

Researchers find possible causes for lacking of effective therapy for multiple sclerosis

Medications currently used to treat multiple sclerosis can merely reduce relapses during the initial relapsing-remitting phase.

20 Aug 2019

Mini kidneys grown in the lab could be used to better understand kidney diseases

An international team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has grown 'miniature kidneys' in the laboratory that could be used to better understand how kidney diseases develop in individual patients.

20 Aug 2019

Simple test could help diagnose glioblastoma

Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.

20 Aug 2019

Researchers develop new gene editing system that could be used for anticancer immunotherapy

Dr. Mihue Jang and her group at the Center for Theragnosis of the Korea Institute of Science and Technology announced that they have developed a new gene-editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the surface of lymphoma cells and activation of cytotoxic T lymphocyte, based on the results of joint research conducted with Prof. Seokmann Hong and his group at Sejong University.

20 Aug 2019

Lipid signaling pathway may enhance T cell-mediated immunotherapy

The immune system surveils our body looking for things that don't belong, often bacteria and viruses. While cancer cells are abnormal cells that undergo unregulated cell growth, they are good at evading detection by the immune system.

19 Aug 2019

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

Pancreatic cancer is one of the deadliest cancers, with patients surviving on average less than a year once the disease has spread.

19 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists funded by the SNSF have created a new compound for flexible drug delivery that specifically targets prostate cancer cells. Incorporating four different molecules, the compound prevents tumor cells from multiplying, can be detected by medical imaging and has staying power in the bloodstream.

19 Aug 2019

Efficacy News and Research

Researchers target cancer's protective barrier

Addiction clinics market pricey, unproven treatments to desperate patients

New insights into improving function, independence and quality of life in cerebral palsy patients

Head-to-head comparison of three breast cancer drugs reveals important differences

Slow electrons to fight cancer

New cannabis-based drug shows promise for pancreatic cancer

Massage Therapy Foundation announces research grant to address pain and opioid use in veterans

'The Hemp and CBD Expo' returns to Birmingham on September 14-15th, 2019

Northern Antibiotics working on a new molecule to fight antibiotic-resistant bacteria

Measles back in UK three years after elimination

Ohio University scientists win $1.7 million grant for research on non-melanoma skin cancers

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients

Researchers find possible causes for lacking of effective therapy for multiple sclerosis

Mini kidneys grown in the lab could be used to better understand kidney diseases

Simple test could help diagnose glioblastoma

Researchers develop new gene editing system that could be used for anticancer immunotherapy

Lipid signaling pathway may enhance T cell-mediated immunotherapy

Study shows synergistic effects of drugs that inhibit cell division in pancreatic cancer

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

Chemists develop new approach based on graphene nanoflakes for drug delivery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News